JOURNAL ARTICLE
Add like
Add dislike
Add to saved papers

[Cutaneous vasculitis revealing a Mycoplasma pneumoniae infection].

La Presse Médicale 2004 November 7
INTRODUCTION: Mycoplasma pneumoniae is a bacterial agent that must be evoked when confronted with cutaneous vasculitis, notably within a context of fever and inflammation, and despite the absence of respiratory symptoms.

OBSERVATION: A young 16 year-old boy was hospitalised for cutaneous vasculitis with fever but without respiratory symptoms. A recent M. pneumoniae sero-conversion was revealed.

DISCUSSION: M. pneumoniae is an intra-cellular pathogen responsible for 20 to 35% of community-acquired pneumonia in adults. The absence of respiratory symptoms in M. pneumoniae infection is not uncommon. Extra-pulmonary complications of M. pneumoniae infections are frequent and varied, notably dermatological. Cutaneous vasculitis associated with M. pneumoniae is seldom found in the medical literature. It is reported as immune-complex -mediated vasculitis or Henoch-Schonlein purpura. Cutaneous eruptions are dominated by maculo-papular rashes and multiform erythema.

Full text links

For the best experience, use the Read mobile app

Group 7SearchHeart failure treatmentPapersTopicsCollectionsEffects of Sodium-Glucose Cotransporter 2 Inhibitors for the Treatment of Patients With Heart Failure Importance: Only 1 class of glucose-lowering agents-sodium-glucose cotransporter 2 (SGLT2) inhibitors-has been reported to decrease the risk of cardiovascular events primarily by reducingSeptember 1, 2017: JAMA CardiologyAssociations of albuminuria in patients with chronic heart failure: findings in the ALiskiren Observation of heart Failure Treatment study.CONCLUSIONS: Increased UACR is common in patients with heart failure, including non-diabetics. Urinary albumin creatininineJul, 2011: European Journal of Heart FailureRandomized Controlled TrialEffects of Liraglutide on Clinical Stability Among Patients With Advanced Heart Failure and Reduced Ejection Fraction: A Randomized Clinical Trial.Review

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

Read by QxMD is copyright © 2021 QxMD Software Inc. All rights reserved. By using this service, you agree to our terms of use and privacy policy.

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app